Back to News
Market Impact: 0.2
PetMeds CEO Transition: Jeff Willard To Succeed Leslie Campbell
Source: Nasdaq
Management & GovernanceConsumer Demand & Retail
PetMed Express (PETS), operating as PetMeds and parent of PetCareRx, appointed Jeff Willard as CEO, president and a board member, effective September 28, 2026. The announcement provides a leadership transition update but includes no financial targets, operating outlook, or strategic details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
PETS0.20
More News
- Ryanair warns of €2 bln higher fuel bill next year as H1 profit falls 15%
- Bangladesh garment factories disrupted as protests continue for third day
- Tesla registrations jump in Sweden, Norway and Denmark
- Apple’s new CEO Ternus to face first earnings test as memory costs surge
- Sam Altman makes surprise South Korea visit as OpenAI builds on chip partnerships
- Barclays downgrades Dr. Martens to underweight, cuts price target